BOSTON ( TheStreet) -- The Credit Suisse Focus List, which has outperformed the S&P 500 in each of the past six years, included 18 stocks at the start of 2011. Here's a snapshot of this year's five best-performing picks from the Zurich, Switzerland-based bank.
Now, here are five Focus List stocks, still rated "outperform", that offer as much as 79% upside.
5. Cytec (CYT - Get Report) is a specialty chemicals and materials company, based in Woodland Park, N.J. Its stock has gained 13% in the past 12 months, but has declined 2% in 2011. Cytec's fourth-quarter net income more than quadrupled to $48 million, or 81 cents a share, even though revenue fell 7% to $700 million. Cytec's gross margin narrowed from 25% to 22% and its operating margin tightened from 6.9% to 6.6%. The company held $383 million of cash and $648 million of debt at quarter's end, for an ample quick ratio of 1.4 and a debt-to-equity ratio of 0.4.Of analysts covering Cytec, four, or 57%, advise purchasing its stock, two say to hold and one advocates selling. Credit Suisse expects the shares to climb 28% to $67. KeyBank is even more optimistic, with a 12-month target of $68. In contrast, Goldman Sachs ranks Cytec "sell", but values its stock at $54, marginally above the current market price. Cytec sells for a trailing earnings multiple of 18, a forward earnings multiple of 13, a book value multiple of 1.5, a sales multiple of 0.9 and a cash flow multiple of 9.3, 15%, 21%, 63%, 64% and 30% industry discounts.